Ginkgo Bioworks Holdings Price to Book Ratio 2020-2022 | DNA

Historical price to book ratio values for Ginkgo Bioworks Holdings (DNA) over the last 10 years. The current price to book ratio for Ginkgo Bioworks Holdings as of August 12, 2022 is 3.96.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Ginkgo Bioworks Holdings Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2022-08-12 3.63 3.65
2022-03-31 4.03 $1.00 4.05
2021-12-31 8.31 $0.97 8.54
2021-09-30 11.59 $1.09 10.65
2021-06-30 9.96 $0.07 137.57
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $6.449B $0.314B
Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $161.361B 9.79
GSK (GSK) United Kingdom $73.273B 8.80
Bio-Rad Laboratories (BIO.B) United States $15.412B 34.05
QIAGEN (QGEN) Netherlands $11.336B 18.98
Biohaven Pharmaceutical Holding (BHVN) United States $10.564B 0.00
Arcus Biosciences (RCUS) United States $1.963B 38.31
Myovant Sciences (MYOV) United Kingdom $1.774B 0.00
Emergent Biosolutions (EBS) United States $1.521B 8.82
Zymeworks (ZYME) Canada $0.430B 0.00
Enzo Biochem (ENZ) United States $0.130B 0.00
Gelesis Holdings (GLS) United States $0.118B 0.00
SQZ Biotechnologies (SQZ) United States $0.099B 0.00
Ambrx Biopharma (AMAM) United States $0.095B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00